Obese men and women given 3.75 mg of controlled-release phentermine plus 23 mg of controlled-release topiramate (Topamax)—the trade name of this drug combination is Qnexa—lost ...

RCT: Low-dose, controlled-release, phentermine plus topiramate in overweight and obese adults (CONQUER)

UK Medicines Information for NHS professionals ... Trade Name: Qnexa : Entry Type: New formulation : Developmental Status: UK: Pre-registration (Filed)

FDA requests birth defect data for Qnexa® (phentermine and topiramate)

Positive caloric balance often causes pathologic adipocyte and adipose tissue anatomical and functional changes (termed adiposopathy or 'sick fat'), which may l...

The experimental appetite suppressant drug Qnexa is a mixture of Phentermine and Topiramate. The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee reviewed Qnexa on July ...

The combination of phertermine and topiramate resulted in substantial weight loss and good tolerability, according to a press release from Vivus Inc, the manufacturer of the ...

Testimony on Phentermine and Topiramate (Qnexa) July 15, 2010. Testimony before FDA's Endocrinologic and Metabolic Drugs Advisory Committee Sidney Wolfe, M.D. Charles Preston ...

Updated– The experimental diet drug combination of phentermine and topiramate demonstrated “robust efficacy” in CONQUER, a large new trial published online in the Lancet.

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised ...

Phentermine plus topiramate in the treatment of obesity – Authors' reply. By - Kishore M Gadde, Donna H Ryan, Craig A Peterson, Wesley W Day

Previous Brain Posts summarized some of the pharmacologic agents in the pipeline for weight loss as well as some drug combinations. A recent research study published ...

Long-term weight loss with controlled-release phentermine/topiramate appears to reverse metabolic syndrome and improve associated traits, according to results released at the ...

The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.

BioInfoBank Library :: Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease. Acknowledgements. Obesity in 2010 ...

Clinical Trials - clinicaltrials.gov The primary objective of this study is to describe the single- and multiple-dose pharmacokinetic profiles of two novel for...